These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 15533765)

  • 1. Withdrawing antimalarial drugs: impact on parasite resistance and implications for malaria treatment policies.
    Laufer MK; Plowe CV
    Drug Resist Updat; 2004; 7(4-5):279-88. PubMed ID: 15533765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
    Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP
    P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanisms and epidemiology of resistances to antimalarials].
    Le Bras J; Basco LK; de Pécoulas PE
    C R Seances Soc Biol Fil; 1996; 190(4):471-85. PubMed ID: 8952898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chloroquine-resistant malaria.
    Wellems TE; Plowe CV
    J Infect Dis; 2001 Sep; 184(6):770-6. PubMed ID: 11517439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of drug-resistant malaria in Republic of Congo: using molecular evidence for monitoring antimalarial drug resistance combined with assessment of antimalarial drug use.
    Nsimba B; Jafari-Guemouri S; Malonga DA; Mouata AM; Kiori J; Louya F; Yocka D; Malanda M; Durand R; Le Bras J
    Trop Med Int Health; 2005 Oct; 10(10):1030-7. PubMed ID: 16185238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
    Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
    Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing national treatment policy for falciparum malaria in Africa: Malawi experience.
    Malenga G; Wirima J; Kazembe P; Nyasulu Y; Mbvundula M; Nyirenda C; Sungani F; Campbell C; Molyneux M; Bronzan R; Dodoli W; Ali D; Kabuluzi S
    Trans R Soc Trop Med Hyg; 2009 Apr; 103 Suppl 1():S15-8. PubMed ID: 19285699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Malaria and drug resistance].
    Kager PA; Wetsteyn JC
    Ned Tijdschr Geneeskd; 1996 Jan; 140(3):151-5. PubMed ID: 8618636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolutionary paradigm of chloroquine-resistant malaria in India.
    Das A; Dash AP
    Trends Parasitol; 2007 Apr; 23(4):132-5. PubMed ID: 17280870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fitness of drug-resistant malaria parasites.
    Walliker D; Hunt P; Babiker H
    Acta Trop; 2005 Jun; 94(3):251-9. PubMed ID: 15845348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Limits of the efficacy of chloroquine and sulfadoxine-pyrimethamine in Northern Abidjan (Cote d'Ivoire): Combined in vivo and in vitro studies].
    Djaman J; Abouanou S; Basco L; Koné M
    Sante; 2004; 14(4):205-9. PubMed ID: 15745869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimalarial drugs and their ways to use in the African milieu.
    Zoguéreh DD; Delmont J
    Sante; 2000; 10(6):425-33. PubMed ID: 11226940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should chloroquine be laid to rest?
    Ginsburg H
    Acta Trop; 2005 Oct; 96(1):16-23. PubMed ID: 16054105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low level genotypic chloroquine resistance near Malawi's northern border with Tanzania.
    Bridges DJ; Molyneux M; Nkhoma S
    Trop Med Int Health; 2009 Sep; 14(9):1093-6. PubMed ID: 19624477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemical resistance of Plasmodium falciparum in Africa. Current situation, implications for chemoprophylaxis].
    Sansonetti PJ; Charmot G
    Biomed Pharmacother; 1987; 41(4):167-71. PubMed ID: 3304439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-resistant malaria in Bangui, Central African Republic: an in vitro assessment.
    Menard D; Djalle D; Manirakiza A; Yapou F; Siadoua V; Sana S; Matsika-Claquin MD; Nestor M; Talarmin A
    Am J Trop Med Hyg; 2005 Aug; 73(2):239-43. PubMed ID: 16103582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current drugs for the treatment of tropical malaria].
    Fernex M; Jaquet C; Mittelholzer ML; Reber R; Stürchler D
    Schweiz Rundsch Med Prax; 1991 Jan; 80(4):67-71. PubMed ID: 1998081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chloroquine resistance and malaria control in Ivory Coast].
    Henry MC; Koné M; Guillet P; Mouchet J
    Sante; 1998; 8(4):287-91. PubMed ID: 9794040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular surveillance for drug-resistant Plasmodiumfalciparum malaria in Malawi.
    Nkhoma S; Molyneux M; Ward S
    Acta Trop; 2007 May; 102(2):138-42. PubMed ID: 17544355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of chloroquine (CQ) and sulphadoxine/pyrimethamine (SP) therapy in uncomplicated falciparum malaria in Indo-Myanmar border areas.
    Mohapatra PK; Prakash A; Taison K; Negmu K; Gohain AC; Namchoom NS; Wange D; Bhattacharyya DR; Goswami BK; Borgohain BK; Mahanta J
    Trop Med Int Health; 2005 May; 10(5):478-83. PubMed ID: 15860095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.